Position in DXCM
as of Mar 31, 2026
· filed Apr 10, 2026
Position Value
$2,541,076
-$601,145 QoQ
Shares Held
40,463
-14.5% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026OP Asset Management Ltd holds $65,178,241 across 15 Medical Devices names. DXCM ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
175,772 | $18,046,511 | |
| 2 | SYK |
Stryker Corp
|
36,504 | $11,994,849 | |
| 3 | EW |
Edwards Lifesciences Corp
|
137,471 | $11,008,677 | |
| 4 | BSX |
Boston Scientific Corp
|
150,097 | $9,418,586 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
46,309 | $3,296,274 | |
| 6 | DXCM |
Dexcom Inc
This page
|
40,463 | $2,541,076 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
20,650 | $1,867,173 | |
| 8 | BIO |
Bio-Rad Laboratories, Inc.
|
6,552 | $1,826,370 |
All Filings in DXCM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,541,076 | 40,463 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $3,142,221 | 47,344 | Shares | Sole | 2026-04-21 | |
| 2025-09-30 | $3,185,777 | 47,344 | Shares | Sole | 2026-04-20 | |
| 2025-06-30 | $4,006,698 | 45,901 | Shares | Sole | 2026-04-20 | |
| 2025-03-31 | $3,235,921 | 47,385 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||